Navigation Links
North Carolina Company Announces First Chronic Pain Control Unit Combining Two Most Used Forms of Electrotherapy For Chronic Pain - Tens & Interferential
Date:1/13/2009

Portable device can be used in home, rather than hospital, and can be worn for treatment anytime, anywhere, including work.

(PRWEB) January 13, 2009 -- MedFaxx has announced the release of the first FDA approved, insurance reimbursable unit that combines the most used form of electrotherapy in the world clinically for chronic pain, interferential with TENS (transcutaneous electrical nerve stimulation) which is the most used form of electrotherapy for chronic pain outside the clinic. The Infrex Plus unit means those individuals suffering from agonizing pain can now self-treat without the use of narcotics, at home or work, on an as needed basis.

Historically interferential (8,000+ pulses per second) was only used for patients in a clinical setting. Each session cost the patient or insurance company for each treatment. The benefit of interferential is immediate pain relief that provides 'carryover' pain relief that can last for hours, days, and sometimes weeks.

With the release of the new combination unit a patient can treat at home, work, or wherever pain starts, whenever it starts. The patient is no longer dependent upon scheduling an appointment, being denied treatment by the insurance company, or having to take time off from work to get relief. The new unit is small enough, yet powerful enough, for the patient to wear/carry and use during breaks or on the job to self treat to.

The overall savings from missing work will be in the mega millions of dollars for the employer and employee.

Bob Johnson of MedFaxx Inc. said: "The Infrex Plus unit means those individuals suffering from agonizing pain can now self-treat without the use of narcotics, at home or work, on an as needed basis."

The breakthrough is the result of new-patented engineering technology that allows the use of portable, rechargeable batteries that can sustain enough energy for the patient to receive up to two treatments using only the battery system. In most settings, it is preferred the unit be plugged into a wall outlet with the AC adaptor. The engineering efficiency of using either batteries or AC adaptor means more patients can stay on the job, be active with their families, and not worry about the onset of crippling pain.

Interferential is not new. It's been around since 1951 but has been regarded as "experimental" by Medicare even though it is the most effective form of electrotherapy for pain in the world. Due to the classification, Medicare patients had to be treated with interferential only in clinical settings. Medicare would deny the purchase of an interferential unit, even though the patient's pain was resolved. The new Infrex Plus unit solved this problem by combining a Medicare approved unit, TENS, with the interferential mode into one unit so a patient can choose which treatment is best and have the unit paid for by the insurance company, including Medicare.

The overall savings to the U.S. health care system will be significant. Patients can obtain relief without having to go to clinics. This dramatically reduces the cost of chronic pain management to patients, insurance companies, and Medicare.

The company, MedFaxx, offers a free trial of the Infrex Plus unit, for the patient to determine its efficacy before any purchase is made. During the trial, the company consults with the insurance company to make sure coverage is provided and if not MedFaxx will work with any patient to insure the patient is treated.

For over 30+ years the company has operated on the premise that no deserving patients will be denied access to its equipment due to lack of funds. As the only unit approved by the FDA., a prescription is required from a licensed medical doctor before the unit can be sent for the free trial. The company works with the patient and doctor to facilitate this process. For a free trial visit here: http://www.painreductiontherapy.com/infrex1.php

More information can be obtained by visiting the website, http://www.medfaxxinc.com or by calling Bob Johnson at 800-937-3993 - 9 a.m. - 5 p.m. EST.

###

Read the full story at http://www.prweb.com/releases/MedFaxx/Infrex-Plus/prweb1779274.htm


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Summa Health System Performs Northeast Ohios First Robotic Lobectomy
2. Baxter and Northwestern University partner to target new life sciences projects
3. UJC and Jewish Federations of North America Commit $10 Million for Needs in Southern Israel
4. Northern Lake Medical to Join Aurora Health Care
5. Houston Northwest Medical Center Is Recognized as a Certified Quality Breast Center(TM) by the National Consortium of Breast Centers
6. S*BIO Announces Collaboration with Onyx for JAK2 Inhibitors in the North American and European Markets
7. MAQUET opens North Americas first VARIOP prefabricated operating suite system
8. MAQUET Opens North Americas First VARIOP Prefabricated Operating Suite System, Allowing Space Reconfiguration in Hours, Less Disruption Than Traditional Construction
9. Compass Group North America Acquires KIMCO Corporation
10. Ken Horowitz Joins North Star Health as Chief Executive Officer
11. Specialists On Call Expands Access to Emergency Neurology On-Call Services in North Carolina
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
North Carolina Company Announces First Chronic Pain Control Unit Combining Two Most Used Forms of Electrotherapy For Chronic Pain - Tens & Interferential
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... a breakthrough topical cream that’s the first in a new class of photodynamic ... the overall appearance of skin, visibly reduce outward signs of aging, and minimize ...
(Date:4/25/2017)... ... April 25, 2017 , ... As President Trump challenges ... for how his administration could impact the employee benefits industry. James Slotnick, AVP, ... most likely to make it through Congress. His discussion will focus on the ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... rely on contracted partners to help with process innovation in drug formulation and ... formulation experience along with state-of-the-art analytical equipment in support of their development and ...
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, a ... its patient care management module. Using this new feature, sleep physicians can now ... initiated on continuous positive airway pressure (CPAP), oral, or other forms of sleep ...
(Date:4/24/2017)... ... April 24, 2017 , ... Emmanuel College is introducing ... advance their careers. Beginning in the fall of 2017, Emmanuel’s program will allow registered ... few as 16 months and for as little as $14,528. These changes will enable ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... India , April 19, 2017 ... and Application, Forecast to 2022 report has covered and analysed ... statistics and information on market size, shares and growth factors. ... major drivers, challenges and opportunities in the global market. ... Browse 152 Tables and Figures, ...
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
(Date:4/19/2017)... , April 19, 2017  Novartis today ... the National Heart, Lung, and Blood Institute (NHLBI) ... that 58% of patients with treatment-naïve severe aplastic ... when treated with eltrombopag at the initiation of ... The study evaluated three sequential treatment groups, or ...
Breaking Medicine Technology: